Product Description
A surgical sealant film is an implantable medical device used during surgery. It is a preformed flexible patch that is applied to supplement sutures and surgical staples to seal tissues and prevent leaks of fluid (including blood and cerebrospinal fluid) and air.
The Synthetic Surgical Sealant market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031.
Considering the influence of COVID-19 on the global Synthetic Surgical Sealant market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.
This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.
Under COVID-19 Outbreak, how the Synthetic Surgical Sealant Industry will develop is also analyzed in detail in Chapter 1.8 of this report.
Major Players in Synthetic Surgical Sealant market are:
Sanofi Group
C.R. Bard, Inc.
Ocular Therapeutix, Inc.
Baxter International, Inc.
Vivostat A/S
Johnson & Johnson (Ethicon, Inc.)
Medtronic PLC
B. Braun Melsungen AG
Cryolife, Inc.
Cohera Medical, Inc.
Sealantis Ltd.
Most important types of Synthetic Surgical Sealant products covered in this report are:
Cyanoacrylates
Polyethylene glycol Hydrogels
Urethane-based Adhesives
Most widely used downstream fields of Synthetic Surgical Sealant market covered in this report are:
Surgical Hemostasis
Tissue Sealing
Tissue Engineering
Major Regions or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others
In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.
In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.
In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.
